Service Corporation International

source: coverage-next-full ticker: SCI company: Service Corporation International step: 01 title: Business Overview & Value Chain date: 2026-05-27

Step 01 — Business Overview: Service Corporation International (SCI)

1. Executive Summary

Service Corporation International (SCI) is the largest death care services company in North America, operating funeral homes, cemeteries, and cremation centers. Founded in 1962 by Robert Waltrip in Houston, Texas, SCI has grown from a single funeral home to a 1,489-location funeral network and 496-cemetery portfolio through disciplined, decades-long consolidation [S1]. The company's competitive position is grounded in three structural advantages: (1) its unmatched geographic scale under the Dignity Memorial brand, (2) a $17.0 billion preneed contract backlog providing exceptional future revenue visibility, and (3) irreplaceable real estate assets in the cemetery business [S2].

2. Business Model

SCI operates a two-segment model:

Segment 1: Funeral (~55.8% of 2025 revenue)

• Provides full-service funeral and cremation arrangements, both at-need (immediate death) and preneed (pre-arranged)
• Revenue sources: funeral services, casket sales, flower sales, transportation, memorialization
• Key brands: Dignity Memorial (full-service), National Cremation Society, Neptune Society (cremation)
• Revenue per call (average): ~$5,500–$6,000 (traditional); ~$2,000–$3,000 (direct cremation)
• 2025 funeral revenue: ~$2,406M; gross margin: ~20.6%

Segment 2: Cemetery (~44.2% of 2025 revenue)

• Sells cemetery property (burial plots, niches, mausoleums) and provides interment services
• Also sells pre-need property rights (cemetery real estate sold well in advance)
• Higher margins than funeral due to real estate component
• 2025 cemetery revenue: ~$1,904M; gross margin: ~33.8%

3. Value Chain Layer Map

[UPSTREAM]
  Merchandise procurement (caskets, urns, vaults, flowers)
  Insurance carrier partnerships (preneed insurance funding)
  Cemetery land acquisition and perpetual care
  Funeral home acquisitions

[OPERATIONS CORE]
  Funeral directors (licensed professionals — state regulated)
  Cremation technicians
  Cemetery managers and groundskeepers
  Preneed sales counselors (commissioned sales force)
  Trust fund management (state-mandated trusts for preneed funds)

[CUSTOMER DELIVERY]
  At-need funeral arrangements (48–72 hour urgency)
  Cremation processing
  Cemetery interments and memorialization
  Grief support services

[DOWNSTREAM / FOLLOW-ON]
  Preneed contract fulfillment (future revenue recognition)
  Trust fund investment returns
  Adjacent plot sales to family members of existing customers
  Preneed insurance claims (insurance-funded preneed)

4. Revenue Model Detail

At-Need Revenue: Recognized at time of service delivery; driven by death volume × average revenue per call. Subject to quarterly volatility from flu seasons, COVID waves, etc.

Preneed Revenue Recognition: Complex multi-step:

1. Customer signs preneed contract and pays
2. Cash deposited into state-mandated trust or used to purchase insurance policy
3. Revenue recognized upon delivery of the service (at death), not at sale
4. Trust fund investment returns flow into revenue as earned
5. Cemetery property (real estate) is recognized at time of sale (distinct from services)

Trust & Insurance Backlog: $17.0B preneed backlog (2025) represents contracts sold but not yet delivered. This is locked-in future revenue that will be recognized at death. ~$8.2B sits in trust assets (2025).

5. Operating Locations (March 2025)

6. Preneed Sales Engine

SCI's preneed sales force is a key differentiator:

• ~3,500 preneed sales counselors (estimate)
• Both funeral preneed and cemetery preneed sold in advance
• 2025 preneed funeral production: $1,198M
• 2025 preneed cemetery production: $1,421M
• Total 2025 preneed production: ~$2,619M

Preneed sales lock in future volume, reduce at-need volume dependency, and create an annuity-like backlog.

7. Key Brand Portfolio

8. Strategic Positioning

SCI competes primarily on trust, brand recognition, and geographic convenience rather than price. Key strategic thrusts:

1. Cremation monetization: Growing cremation volume while maintaining revenue per call through ancillary products and preneed
2. Preneed expansion: Higher preneed penetration increases backlog and reduces at-need volatility
3. Bolt-on M&A: ~20–30 funeral homes and occasional cemeteries acquired annually
4. Capital return: ~$600M+ returned to shareholders annually (buybacks + dividends)
5. Technology: Online funeral planning tools, e-commerce for flowers/merchandise

9. Source Index

source: coverage-next-full ticker: SCI company: Service Corporation International step: 04 title: Financial Quality & Adversarial Research Sweep date: 2026-05-27

Step 04 — Financial Quality & Adversarial Research Sweep: SCI

1. Income Statement Quality Assessment

1a. Revenue Recognition Complexity

SCI's revenue recognition is nuanced and creates legitimate complexity — not manipulation, but analysts must understand it [S1]:

1. Preneed revenue deferral: Cash collected from preneed contracts does NOT flow through revenue at sale. Revenue is only recognized upon service delivery. This creates a large deferred revenue liability ($1.78B on-balance-sheet) and $17B in trust-backed future obligations.
2. Trust fund income: Investment returns on preneed trusts are recognized as revenue in the period earned. This creates volatility tied to capital markets (rising in bull markets, declining in bear markets).
3. Preneed merchandise: Cemetery merchandise (vault, marker) is recognized when installed, not when sold. This creates timing differences.

Assessment: Revenue recognition is conservative and well-established. Deferred revenue model protects consumers and creates strong future visibility.

1b. COVID Distortion

FY2021 results ($4.14B revenue, $803M net income, $4.72 EPS) are materially distorted by elevated COVID-related deaths. Analysts using 2021 as a baseline for trend analysis will overstate SCI's organic growth. The correct baseline is 2022–2025 normalized results:

• Revenue: $4.1–$4.3B (2022–2025 range)
• Gross margin: 26–28% (vs. COVID-inflated 31.9% in 2021)
• Net income: $519–$565M (excluding COVID windfall)

Adjustment: Exclude 2021 when calculating 3-year averages for margin analysis.

1c. EPS vs. Net Income Divergence

EPS grew from $3.53 (2022–2023) to $3.80 (2025) while net income was roughly flat (~$540M). The growth is entirely buyback-driven — shares outstanding declined from 153.9M (2022) to 139.7M (2025), a 9.2% reduction. EPS growth investors should note this is financial engineering, not earnings growth — though disciplined buybacks at these multiples do create value.

2. Balance Sheet Quality Assessment

2a. Debt and Leverage

Assessment: Leverage is elevated but manageable given the predictability of SCI's OCF ($900M+ annually). The company has consistently maintained ~3.5–4.0x leverage through the cycle. Investment-grade credit rating (Moody's, S&P) allows low-cost debt financing.

Risk: Leverage is rising (~$400M net debt increase in 2025 vs. 2024). At some point, this limits buyback capacity or requires asset sales.

2b. Goodwill Quality

Goodwill increased to $2,169M (2025) from $1,915M (2021), reflecting acquisitions. As a % of total equity: ~132% (goodwill exceeds book equity). This is elevated but common for serial acquirers in service businesses where intangibles (brand, licenses, preneed customer relationships) dominate asset value.

Key question: Has SCI overpaid for acquisitions? See Step 07 for M&A deep dive.

2c. Trust Fund Assets — Largest Balance Sheet Item

SCI's $18.7B total assets (2025) include ~$8.2B in preneed trust investments [S2]. These are offset by corresponding preneed trust liabilities — they are not "free" assets. Net position of trust assets vs. trust liabilities matters for cash generation analysis.

Trust investments: fixed income + equities managed by third parties. Market value fluctuations affect recognized trust income but not balance sheet principal for GAAP.

3. Cash Flow Quality Assessment

3a. Operating Cash Flow vs. Net Income (Reconciliation)

OCF consistently exceeds net income by a significant margin, driven by non-cash items (depreciation ~$350M, trust income timing). This is a quality indicator — earnings are being backed by real cash.

3b. Free Cash Flow Analysis

Note: CapEx from StockAnalysis (PaymentsToAcquireProductiveAssets); 2025 CapEx of $388.6M confirmed in press release

FCF yield at current $10.6B market cap: ~5.2% (2025 FCF). This is modestly attractive for a high-quality defensive business.

CapEx intensity: ~9% of revenue in maintenance + growth CapEx. Company guides to ~$325M maintenance CapEx for 2026. The ~$65M above maintenance in 2025 represents growth/cemetery development.

4. Adversarial Research Sweep

Examining short theses, lawsuits, investigations, and bear case arguments

4a. California AG Settlement (2024)

Finding: California Attorney General reached a $23M settlement with SCI affiliates for violations of Unfair Competition Law and False Advertising Law related to preneed cremation marketing. Alleged misleading sales practices around direct cremation packages [S3].

Assessment: $23M is ~2.5% of a single year's OCF — immaterial financially. However, it raises questions about SCI's aggressive preneed sales practices. Company agreed to comprehensive injunctive relief and full customer restitution. Risk to watch: Similar state investigations in FL, TX, NY where SCI has large concentration.

4b. Preneed Marketing Controversy — Recurring Pattern

Industry critics and state regulators periodically investigate death care companies for high-pressure preneed sales tactics targeting elderly consumers. SCI has faced:

• State-level investigations in multiple jurisdictions historically
• Consumer complaint databases show recurring issues with preneed sales counselor conduct
• FTC Funeral Rule complaints

Assessment: Systemic risk, not idiosyncratic to one event. Manageable if company maintains compliance culture.

4c. Bear Case: Cremation Revenue Compression

The most serious structural bear argument: cremation mix will rise to 80%+ by 2045, compressing revenue per call by 40–50% over two decades. Even with pricing discipline, lower-cost cremation fundamentally changes unit economics.

Counter: (1) SCI is pricing cremation profitably; (2) cemetery remains burial/memorialization focused even for cremated remains; (3) preneed pricing locks in today's rates; (4) volume tailwind partially offsets per-call compression.

Assessment: Real, long-term headwind. Not existential, but limits revenue growth potential. Market appears to have appropriately discounted this.

4d. Debt Accumulation Concern

Net debt grew from ~$3.7B (2020) to ~$4.9B (2025) — a $1.2B increase over 5 years while the company has generated ~$4.5B in cumulative OCF. The debt growth is explained by $2.9B in buybacks, $900M in dividends, and $560M in acquisitions — net $4.4B returned/deployed vs. $4.5B OCF. Leverage is rising but is a deliberate financial policy, not operational deterioration.

Assessment: At 3.9x Net Debt/EBITDA, SCI is at the high end of management's target. A recession or investment-grade credit downgrade could increase interest costs. Watch if Net Debt/EBITDA approaches 4.5x.

4e. SCI Not a Growth Story

Short sellers and value skeptics point out: SCI's revenue has grown just 4.0% total from 2022 to 2025 ($4.11B → $4.31B), essentially flat. Post-COVID normalization means the company faces a multi-year period of slow revenue growth. EPS "growth" is entirely financial engineering (buybacks).

Assessment: Accurate. SCI is a capital allocator and income stock, not a growth stock. The bullish case depends on: (1) demographic tailwind materializing 2028+; (2) pricing power continuing; (3) buybacks at current low P/E accreting to value. Investors expecting revenue growth will be disappointed.

5. Accounting Policy Notes

No material accounting concerns identified. SCI's financials are clean and consistent.

6. Financial Quality Score

7. Source Index